Are there cardiotoxicity clinical trials in New Jersey?

Yes. We're currently tracking 4 recruiting cardiotoxicity studies with a site in New Jersey, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a cardiotoxicity study in New Jersey?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in New Jersey to take part?

Not necessarily. These studies have a site in New Jersey, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a cardiotoxicity trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · New Jersey

Cardiotoxicity clinical trials in New Jersey

We’re tracking 4 recruiting cardiotoxicity studies with a site in New Jersey — including Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in New Jersey

NCT05256745RecruitingPhase 1/Phase 2
A medicine to protect the heart during breast cancer chemotherapy
This early-phase study tests azeliragon to lower the risk of chemotherapy-related heart damage in women with early-stage breast cancer. Participants get their planned standard chemotherapy, plus the study medicine, and are monitored for safety and heart health.
Hackensack, New JerseyAges 18 years+
NCT03418961RecruitingPhase 3
Study of heart-risk management for metastatic HER2 breast cancer
This trial follows people with metastatic HER2-positive breast cancer who are at higher risk for heart damage while on HER2-targeted therapy. Some participants are randomly assigned to different monitoring/heart-protection approaches to see what best helps keep the heart safe.
Summit, New JerseyAges 18 years+
NCT06023576RecruitingPhase 2
Blood pressure control during breast cancer chemo
This study tests whether careful blood pressure management can help protect the heart during certain types of chemotherapy (anthracyclines) for breast cancer. Participants will use a smart blood pressure device and may also do an exercise test.
Basking Ridge, New JerseyAges 18 years+
NCT06699056Recruiting
AI heart monitor study for ejection fraction
This study uses an AI-powered wearable monitor to check how well your heart pumps blood (ejection fraction) from a simple EKG recording. It may help doctors quickly assess heart function without extra tests.
Hackensack, New JerseyAges 18 years+

Where these studies are running in New Jersey

Institutions with a site for the recruiting cardiotoxicity studies listed above.

Hackensack University Medical Center
Holy Name Medical Center
John Theurer Cancer Center at Hackensack University Medical Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Monmouth
Morristown Medical Center
Newton Medical Center

What taking part in a cardiotoxicity study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Cardiotoxicity trials in other states

Common questions

Are there cardiotoxicity clinical trials in New Jersey?: Yes. We're currently tracking 4 recruiting cardiotoxicity studies with a site in New Jersey, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a cardiotoxicity study in New Jersey?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in New Jersey to take part?: Not necessarily. These studies have a site in New Jersey, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a cardiotoxicity trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New cardiotoxicity studies open in New Jersey regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.